Forum 2026 is a premier invite-only event uniting top pharma and healthcare supply chain leaders. This exclusive platform explores cutting-edge innovations in AI, IoT, blockchain, and cold chain logistics, while fostering valuable networking and...
and biotechnology. Scheduled to take place on October 12–13, 2026, in Singapore, the conference serves as a global platform to exchange knowledge, discuss emerging trends, and foster collaborations that accelerate drug discovery and therapeutic...
Day: Celebrate breakthroughs and emerging players shaping the next generation of therapies. And More to Come: Fresh formats, dynamic networking experiences, and unique ways to connect across disciplines. Be part of the next chapter in life...
technologies and practical solutions. In this 8th edition as we explore the novel technologies and developments reforming pharmaceutical industry, we also dive deep into the implementation and advances in machine learning, deep learning, artificial...
2nd Annual MaxPotent Pharma Summit – a leading international platform bringing together senior executives, regulatory authorities, technology providers, and pharmaceutical innovators dedicated to advancing the future of Highly Potent Active...
patients can now access Foundayo™ (orforglipron) – Eli Lilly Company's newest oral GLP-1 innovation – on the Ro platform, adding to Ro's already comprehensive formulary of FDA-approved GLP-1s. Foundayo™ is a once daily oral treatment for adults...
develop and manufacture high-quality products while maintaining long-term partnerships across the value chain. For more information please visit, www.dexcel-pharma-usa.com
continuous, noninvasive visibility into patients' blood pressure. The module delivers real-time, beat-to-beat arterial waveform data from a noninvasive finger cuff directly to compatible multiparameter patient monitors, helping clinicians close...
Dr. Singal will lead clinical strategy and development as the company advances its initial pipeline focused on transforming care for patients with chronic liver diseases. “Amit is one of the world’s leading authorities on chronic liver disease...
commented, "Entering the K-Pharmacy channel is not just about distribution—it reflects a level of trust earned through formulation expertise and product performance. We will continue to strengthen our presence in professional channels to further...
with neurological conditions, announced its official launch. The company is advancing a proprietary neural interface platform designed to translate brain signals into actionable digital commands, enabling rehabilitation and assistive therapies for...
investigators Bobo Dang and Ting Zhou at Westlake University/Westlake Laboratory reported in Science a high-throughput platform for engineering fast-acting covalent protein therapeutics. Their work, titled "A high-throughput selection system for...
for Open Innovation Bridging Human, Environment and Materials. The aim objective of ICCBS 2026 is to provide a platform for researchers, engineers, academicians as well as industrial professionals from all over the world to present their research...
to support consistent, patient-friendly dressing changes. By providing the necessary materials in a single, easy-to-use format, carePAC™ aims to reduce complexity for patients and caregivers while supporting adherence to provider-directed wound...
Fisher Scientific the world leader in serving science, announced a next-generation, integrated cell line development platform that enables biologics developers to accelerate time to clinic while maintaining regulatory confidence and commercial...
Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, announced that the U.S. Food and Drug Administration (FDA) has extended the review timeline of its Biologics License...
following bispecifics or other BCMA-directed therapies have very limited options. We believe InoPd may deliver a transformative all-oral treatment for RRMM patients and look forward to further evaluating its potential in this Phase 2 trial.” Care...
medicines. He has a strong track record in leading global organizations, scaling operations and driving strategic transformation in complex healthcare environments. Most recently, he served as Group CEO of Pharmanovia, where he led a major...
MVM Partners announced in November 2025, Avanzanite is scaling its European infrastructure into a single, integrated platform across 32 countries – designed to bring rare disease medicines to patients in every European market. “France is essential...
and motor control by replacing neurons lost to the disease, with the goal of achieving functional restoration. For more information please Visit www.oryoncelltherapies.com
